Published in

Karger Publishers, Neonatology, 3(101), p. 179-182, 2011

DOI: 10.1159/000331774

Links

Tools

Export citation

Search in Google Scholar

First Day of Life Reference Values for Pleth Variability Index in Spontaneously Breathing Term Newborns

Journal article published in 2012 by Giuseppe Latini, Lucia Dipaola, Claudio De Felice ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

<i>Background:</i> The perfusion index (PI), derived from the pulse oximetry signal, has been shown to be an accurate predictor for identifying high illness severity in neonates. The plethysmographic variability index (PVI) is a measure of the dynamic change in PI occurring during a complete respiratory cycle. <i>Objectives:</i> The aim of this study was to establish the reference range of PVI in spontaneously breathing term newborns. <i>Methods:</i> PI and PVI values were assessed in 242 term newborns during the first day of life. <i>Results:</i> The median PVI value on the first day of life was 20% [95% confidence interval (CI) for the mean 19–20%; inter-quartile range 15 (95% CI 15–16) – 24 (95% CI 23–24)]. The 10th and 90th percentile cutoff values were 12% (95% CI 11–12) and 28% (95% CI 27–29), respectively, with the 97.5th percentile of 35% (95% CI 34–38). PVI was also significantly influenced by the behavioral status of the newborn, and was positively correlated with PI and pulse rate, while it was inversely correlated with oxygen saturation (p < 0.0001). <i>Conclusions:</i> Our findings suggest: (1) evaluation of PVI values is an easily applicable, noninvasive procedure for monitoring early postnatal respiratory changes in newborns, and (2) the feasibility of a noninvasive pulse-oximeter postnatal screening for early identification of adverse neonatal cardiorespiratory outcomes.